Show simple item record

dc.contributor.authorMcGhee, David J. M.
dc.contributor.authorRitchie, Craig W.
dc.contributor.authorZajicek, John P.
dc.contributor.authorCounsell, Carl E.
dc.date.accessioned2016-06-17T11:40:07Z
dc.date.available2016-06-17T11:40:07Z
dc.date.issued2016-06-16
dc.identifier.citationMcGhee , D J M , Ritchie , C W , Zajicek , J P & Counsell , C E 2016 , ' A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease ' BMC Neurology , vol. 16 , 92 , pp. 1-13 . DOI: 10.1186/s12883-016-0606-3en
dc.identifier.issn1471-2377
dc.identifier.otherPURE: 67349397
dc.identifier.otherPURE UUID: a254e3a3-e242-4d3b-b56a-14eb8056d2dd
dc.identifier.otherScopus: 84975229879
dc.identifier.urihttp://hdl.handle.net/2164/6128
dc.descriptionAcknowledgements This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0707-10124). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection, data analysis, data interpretation, writing of the report or for the decision to submit for publication.en
dc.format.extent13en
dc.language.isoeng
dc.relation.ispartofBMC Neurologyen
dc.rights© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectAlzheimer's diseaseen
dc.subjectParkinson's diseaseen
dc.subjectdisease progressionen
dc.subjectbiomarkersen
dc.subjectclinical trialsen
dc.subjectneuroprotective agentsen
dc.subjectR Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectRP-PG-0707-10124en
dc.subject.lccRen
dc.titleA review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's diseaseen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen, Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen, Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s12883-016-0606-3


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record